EP3221359
AÐFERÐIR VIÐ ÆXLISMEÐFERÐ MEÐ ÞVÍ AÐ NOTA TVÍSÉRTÆKT MÓTEFNI CD3XCD20
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.11.2015EP published:
27.5.2020EP application number:
15801637.8
EP translation filed:
16.7.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
16.11.2035Expiry date:
16.11.2026Next due date:
30.11.2026
Title:
METHODS FOR TUMOR TREATMENT USING CD3XCD20 BISPECIFIC ANTIBODY
Timeline
Today
17.11.2015EP application
27.5.2020EP Publication
16.7.2020Translation submitted
15.8.2020Registration published
16.11.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
SMITH, EricAddress:
Tarrytown New York 10591, US
Name:
DAVIS, SamuelAddress:
Tarrytown New York 10591, US
Name:
VARGHESE, BinduAddress:
Tarrytown New York 10591, US
Name:
KIRSHNER, Jessica R.Address:
Tarrytown New York 10591, US
Name:
THURSTON, GavinAddress:
Tarrytown New York 10591, US
Name:
LOWY, IsraelAddress:
Tarrytown New York 10591, US
Name:
BROWNSTEIN, CarrieAddress:
Tarrytown New York 10591, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201462080716 PDate:
17.11.2014Country:
US
Number:
201562160788 PDate:
13.5.2015Country:
US
Classification
Categories:
C07K 16/28, G01N 33/50, A61K 39/00, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 20.10.2020
Expires: 16.11.2021
Payer: Patice ehf.
Number: 7
Paid: 20.10.2021
Expires: 16.11.2022
Payer: Patice ehf.
Number: 8
Paid: 20.10.2022
Expires: 16.11.2023
Payer: Patice ehf.
Number: 9
Paid: 6.11.2023
Expires: 16.11.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 25.10.2024
Expires: 16.11.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.11.2025
Expires: 16.11.2026
Payer: Árnason Faktor ehf.